loading page

Should patients with epistaxis and nasal packing be admitted during the COVID-19 Pandemic? A retrospective study of 885 adult cases with epistaxis.
  • +5
  • Vasileios Lachanas,
  • Nick Kalogritsas,
  • Georgios Kontorinis,
  • ANNA MPOURONIKOU,
  • Jiannis Hajiioannou,
  • Fani Saini,
  • Hara Maiou,
  • Charalampos Skoulakis
Vasileios Lachanas
University Hospital of Larissa
Author Profile
Nick Kalogritsas
University Hospital of Larissa
Author Profile
Georgios Kontorinis
Institute of Neurological Sciences, Queen Elizabeth University Hospital
Author Profile
ANNA MPOURONIKOU
University Hospital of Larissa
Author Profile
Jiannis Hajiioannou
University Hospital of Larissa
Author Profile
Fani Saini
University Hospital of Larissa
Author Profile
Hara Maiou
University Hospital of Larissa
Author Profile
Charalampos Skoulakis
University Hospital of Larissa
Author Profile

Abstract

Key point: • Being one of the commonest presenting emergencies, epistaxis can increase the pressure on the health service; in times similar to COVID-19 pandemic such pressure can be crucial and challenging to deal with. • Non-absorbable nasal packing and home discharge for selected patients can be a safe and efficient alternative treatment method with low readmission rates (5.3 %); such management can be of tremendous help when the hospital capacity is overwhelmed. • Although such protocols can be challenging to generalize, the presented protocol seems safe, easily adoptable without any significant complications.